Pharmacological probing of type 1 autism.
Hari
H
Manev
Radmila
R
Manev
D000617:Aminoglycosides / Q000627:therapeutic use*; D001321:Autistic Disorder / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics*; D001921:Brain / Q000187:drug effects; D002648:Child; D018388:Codon, Terminator / Q000187:drug effects* / Q000235:genetics*; D016368:Frameshift Mutation / Q000187:drug effects* / Q000235:genetics*; D015870:Gene Expression / Q000235:genetics; D006801:Humans; D008565:Membrane Proteins / Q000187:drug effects* / Q000235:genetics*; D009419:Nerve Tissue Proteins / Q000187:drug effects* / Q000235:genetics*; D010069:Oxadiazoles / Q000627:therapeutic use*
D000617:Aminoglycosides; C403049:CNTNAP2 protein, human; D018388:Codon, Terminator; D008565:Membrane Proteins; D009419:Nerve Tissue Proteins; D010069:Oxadiazoles; C515878:ataluren